smallAccCompHo_0921.xslt
Company Registration No. SC651132 (Scotland)
TAY THERAPEUTICS LIMITED
Financial Statements
for the Period from 01 February 2025 to 31 January 2026

TAY THERAPEUTICS LIMITED

Financial Statements for the period ending 31 January 2026

CONTENTS PAGE
Company Information 2
Statement of Financial Position 3
Notes to the Accounts 4
- 1 -

TAY THERAPEUTICS LIMITED

Financial Statements for the period ending 31 January 2026

Company Information

Company Details
Company Number SC651132
Registered Office LIFE SCIENCES INNOVATION HUB
5 JAMES LINDSAY PLACE
DUNDEE
DD1 5JJ
Directors
Directors who held office during the period were:
MBM SECRETARIAL SERVICES LIMITED   
BELL, Mark, Dr   
SHAH, Sunil Rajen   
SPAREY, Timothy Jason, Dr   
WOODLAND, Christopher Andrew, Dr   
- 2 -

TAY THERAPEUTICS LIMITED

Financial Statements for the period ending 31 January 2026

Statement of Financial Position

12345678910
Notes 2026 2025
£ £
Fixed Assets
Intangible assets 5 990,000 -
Tangible assets 6 - 18,542
Current Assets
Debtors due 571,487 191,329
Cash at bank and in hand 1,684,712 3,067,171
2,256,199 3,258,500
Creditors
Amount falling due within one year (90,168) (87,962)
Net Current Assets 2,166,031 3,170,538
Total Assets less current liabilities 3,156,031 3,189,080
Net Assets 3,156,031 3,189,080
Capital and Reserves
Called up Share Capital 246 246
Share Premium Account 2,683,181 2,683,181
Retained earnings at end of year 472,604 505,653
Shareholder funds 3,156,031 3,189,080
For the year ending 31/01/2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities.
Approved by the Board on 26 May 2026
Christopher Andrew Woodland
Company Registration No. SC651132
- 3 -

TAY THERAPEUTICS LIMITED

Financial Statements for the period ending 31 January 2026

Notes to the Accounts

1. Statutory Information
TAY THERAPEUTICS LIMITED is a private company, limited by shares, registered in Scotland, registration number SC651132.
2. Accounting Policies
Basis of preparing the Financial Statements
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities.
Presentation Currency
The accounts are presented in £ sterling.
- 4 -

TAY THERAPEUTICS LIMITED

Financial Statements for the period ending 31 January 2026

Notes to the Accounts

3. Employees
Average number of employees, including directors, during the year was as follows:
2026 8
2025 12
4. Principal Activity
The principal activity of the company is the development of small molecule therapeutics.
- 5 -

TAY THERAPEUTICS LIMITED

Financial Statements for the period ending 31 January 2026

Notes to the Accounts

5. Intangible Assets
Other Total
Cost £ £
At 01/02/2025 - -
Additions 1,100,000 1,100,000
Disposals - -
Revaluations - -
At 31/01/2026 1,100,000 1,100,000
Amortisation
At 01/02/2025 - -
Charge for the Year 110,000 110,000
On Disposals - -
Other increases/(decreases) - -
At end of period 110,000 110,000
Net book value
At 31/01/2026 990,000 990,000
At 31/01/2025 - -
6. Fixed Assets
Computer Equipment Total
Cost or valuation £ £
At 01/02/2025 68,042 68,042
Additions - -
Disposals (2,855) (2,855)
At 31/01/2026 65,187 65,187
Depreciation
At 01/02/2025 49,500 49,500
Charge for the year 17,908 17,908
Disposals (2,221) (2,221)
At 31/01/2026 65,187 65,187
Net Book Value
At 31/01/2026 - -
At 31/01/2025 18,542 18,542
- 6 -